GNMSF:OTCMKTS
Genmab A/S
US$ ३६७.००
०.००%
(०.००) 1D
अक्टोबर ९, १०:२८:३६ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNMSF...
Mkt. cap
२२.७६ अरब
Avg. vol.
१.३७ हजार
Volume
१८०.००
52-wk high
US$ ३९६.९७
52-wk low
US$ २३२.५०
Beta
०.७३
Shares outstanding
६.२४ करोड
No. of employees
३ हजार
Mkt. cap
२२.७६ अरब
Avg. vol.
१.३७ हजार
Volume
१८०.००
52-wk high
US$ ३९६.९७
52-wk low
US$ २३२.५०
Beta
०.७३
Shares outstanding
६.२४ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
TipRanks
·
१८ घण्टा पहिले
Genmab Reports USD 4.2 Billion in Q3 2026 DARZALEX Net Sales
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S